25 /100
LOW RISK
Score updated May 30, 2026

ATYR — aTyr Pharma, Inc. Dilution Risk Tracker

Track ATYR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATYR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
39%
🔄 Reverse Split 55%
• 50-day avg $0.74 below $1 exchange minimum
🔁 Convertible Conversion 40%
• Significant convertible debt: 19% potential dilution
• Elevated convertible risk (60/100)
🔔 Track ATYR — Get forecast alerts →

💹 Market Data

Market Cap$53.19M
Shares Outstanding98.05M
Float95.61M
Cash$66.51M
Debt$11.70M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 23.1% shares (2025Q4 vs prior)
86 institutional holders · 56.97M shares
#1 FMR LLC 14.70M shares
#2 FEDERATED HERMES, INC. 10.51M shares
#3 BlackRock, Inc. 6.55M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest21.39M
Days to Cover4.5
% of Float22.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2017
xbrl XBRL CONVERTIBLE Dec 31, 2015
4 INSIDER TRANSACTION Feb 04, 2026
4 INSIDER TRANSACTION Feb 04, 2026
4 INSIDER TRANSACTION Feb 04, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ATYR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATYR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ATYR
📊 ATYR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ATYR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.